➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
McKinsey
Dow

Last Updated: June 2, 2020

DrugPatentWatch Database Preview

EFFIENT Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Effient, and what generic alternatives are available?

Effient is a drug marketed by Eli Lilly And Co and is included in one NDA.

The generic ingredient in EFFIENT is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.

Drug patent expirations by year for EFFIENT
Drug Prices for EFFIENT

See drug prices for EFFIENT

Drug Sales Revenue Trends for EFFIENT

See drug sales revenues for EFFIENT

Recent Clinical Trials for EFFIENT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Janssen, LPPhase 4
HonorHealth Research InstitutePhase 2
Boston Scientific CorporationPhase 2

See all EFFIENT clinical trials

Recent Litigation for EFFIENT

Identify potential future generic entrants

District Court Litigation
Case NameDate
ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA2014-03-12
ELI LILLY AND COMPANY v. PAR PHARMACEUTICAL COMPANIES, INC.2014-01-24

See all EFFIENT litigation

PTAB Litigation
PetitionerDate
Lupin, Ltd.2015-10-05
Panacea Biotec Ltd.2015-06-26
Accord Healthcare Inc., USA2015-03-13

See all EFFIENT litigation

Pharmacology for EFFIENT
Synonyms for EFFIENT
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxidanylidene-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ethanoate
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[4,5-c]pyridin-2-yl] acetate
150322-43-3
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone
2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c] pyridine
2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)4,5,6,7-tetrahydrothieno[3,2-c]pyridine
2-acetyloxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
2-acetyloxy-5-(alpha-cycloproylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-C]pyridine
322P433
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate
5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate
5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-2-yl acetate
A809033
AB0005241
AB01274761_02
AB01274761-01
AB1008453
ABP000379
AC-1640
acetic acid [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ester
Acetic acid 5-[2-cyclopropyl-1-(2-fluoro-phenyl)-2-oxo-ethyl]-4,5,6,7-tetrahydro-thieno[3,2-c]pyridin-2-yl ester
ACN-040194
ACT06208
AK327587
AKOS015841187
AM20090728
API0003912
AR-270/43507998
BCP01882
C-58278
CHEBI:87723
CHEMBL1201772
CP0097
CS 747
CS-0657
CS-747
DB06209
DTGLZDAWLRGWQN-UHFFFAOYSA-N
Efient
EN002851
ETH051
Ethanone, 2-(2-(acetyloxy)-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-1-cyclopropyl-2-(2-fluorophenyl)-
Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-
FD7194
FT-0650150
GTPL7562
HMS3604B09
HMS3654D09
HSDB 7995
HY-15284
KS-00000XJY
KS-5301
LY-640315
LY640315
MCULE-1302242257
MLS003882595
MLS006012001
NCGC00188690-01
NCGC00188690-02
P2040
PB23765
Prasita
Prasugrel
Prasugrel (Effient)
Prasugrel [INN:BAN]
Prasugrel, >=98% (HPLC)
prasugrel, 2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone
Prasugrel, 98%
Prasugrel/Effient
PubChem19523
Q-101872
Q-1607
Q416232
s1258
SB20805
SC-20714
SCHEMBL14112007
SCHEMBL245032
SMR002533665
STL232602
SW219175-1
W0064
ZB0747
ZLA0001
zlchem 1
Paragraph IV (Patent) Challenges for EFFIENT
Tradename Dosage Ingredient NDA Submissiondate
EFFIENT TABLET;ORAL prasugrel hydrochloride 022307 2013-07-10

US Patents and Regulatory Information for EFFIENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eli Lilly And Co EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009 AB RX Yes No   Start Trial   Start Trial   Start Trial
Eli Lilly And Co EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-002 Jul 10, 2009 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for EFFIENT

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0542411 SPC021/2009 Ireland   Start Trial SPC021/2009: 20091119, EXPIRES: 20170908
0542411 C300397 Netherlands   Start Trial PRODUCT NAME: PRASUGREL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225
0542411 C00542411/01 Switzerland   Start Trial FORMER REPRESENTATIVE: BOHEST AG, CH
0542411 CA 2009 00024 Denmark   Start Trial
0542411 SPC/GB09/032 United Kingdom   Start Trial PRODUCT NAME: PRASUGREL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/08/503/001 20090225; UK EU/1/08/503/002 20090225; UK EU/1/08/503/003 20090225; UK EU/1/08/503/004 20090225
0542411 300397 Netherlands   Start Trial 300397, 20120909, EXPIRES: 20170908
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.